Hepta Bio detect, monitor, and direct the most effective liver treatment.
Hepta Bio has raised $6.7M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Hepta Bio's investors include Alumni Ventures, Felicis, Illumina Ventures, SeaX Ventures, AME Cloud Ventures.
Hepta Bio is headquartered in San Francisco, United States.
Hepta Bio detect, monitor, and direct the most effective liver treatment.
Hepta Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hepta Bio — Funding & Investors." VCBacked, November 5, 2025, https://www.vcbacked.co/company/hepta-bio. Accessed August 23, 2026.
VCBacked. (2025). Hepta Bio — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/hepta-bio
{{cite web |title=Hepta Bio — Funding & Investors |url=https://www.vcbacked.co/company/hepta-bio |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated